Smofkabiven 12.7 g (Dextrose EMULSION) 12.7 G

SMOFKABIVEN 12.7 G is an intravenous emulsion containing dextrose, designed for nutritional support. This product, manufactured by Fresenius Kabi Canada Ltd, provides essential calories and energy for patients requiring parenteral nutrition.

Strength

12.7 G

Pack Size

986/1477/1970/2463ML

Manufacturer / TM Owner

FRESENIUS KABI CANADA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SMOFKABIVEN 12.7 G is primarily used for nutritional support in patients who cannot consume food orally. This intravenous emulsion provides calories and energy, making it suitable for individuals with malabsorption issues or those recovering from surgery. It is often used in clinical settings to maintain proper nutrition levels when oral intake is not possible.

Side Effects

When administered intravenously, SMOFKABIVEN 12.7 G provides a source of energy and essential nutrients. Patients may experience improved energy levels and overall well-being as the emulsion supports their nutritional needs. However, individual responses can vary, and it is important to monitor for any adverse effects.

Precautions & Warnings

SMOFKABIVEN 12.7 G should be administered under medical supervision to ensure proper dosage and monitoring. Patients with certain medical conditions, such as diabetes or metabolic disorders, should use this product with caution. Always follow the guidelines provided by healthcare professionals to minimize potential risks.

Avoid Interactions

SMOFKABIVEN 12.7 G may interact with other medications or supplements, particularly those affecting blood sugar levels. It is important to inform healthcare providers about all current medications to avoid potential interactions. Additionally, alcohol and certain dietary supplements may influence the effectiveness of this emulsion.

Frequently Asked Questions

SMOFKABIVEN 12.7 G is used for nutritional support in patients who cannot consume food orally, providing essential calories and energy.

SMOFKABIVEN 12.7 G is administered intravenously, typically in a clinical setting under medical supervision.

Common effects include improved energy levels and overall well-being as the emulsion supports nutritional needs.

Patients with diabetes or metabolic disorders should use SMOFKABIVEN 12.7 G with caution and under medical supervision.

Yes, SMOFKABIVEN 12.7 G may interact with medications affecting blood sugar levels, so it is important to inform healthcare providers about all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.